2023 Expert Speakers

2023 Speakers

Discover which expert speakers and KOLs are presenting at the  7th Annual Liquid Biopsy for Precision Oncology Summit this February 2023.  

Adam Brown

Global Medical Affairs Lead, Oncology ctDx

Agilent Technologies

Alessandra Cesano

CMO

ESSA Pharma

Andrea Stevens

Director - Precision Medicine Access Strategy

Janssen

Antje Hoering

President & CEO

Cancer Research & Biostatistics

Brian Baker

Sr. Director, Regulatory Affairs

Regeneron Pharmaceuticals

Carl Barrett

Vice President, Translational Science & Oncology

AstraZeneca

Carl Morrison

Professor Director & Senior Vice President - Molecular Pathology

Roswell Park Comprehensive Cancer Center

Charles Mathews

Managing Director

ClearView Healthcare Partners

Dana Connors

Scientific Program Manager

Cancer Research Partnerships Foundation for the National Institutes of Health

David Bourdon

Director of Assay Development

Epic Sciences

Elizabeth Attias

Chief Strategy and Development Officer

Sermonix Pharmaceuticals

Erin Newburn

Senior Director, Field Applications Scientist

Personalis Inc

Ezra Cohen

Professor

University of California San Diego

Fernando Cruz-Guilloty

Director - Oncology Precision Medicine & Diagnostics

Janssen

Gene Stegeman

National Sales Director - Health & Life Sciences

Quest Diagnostics

George Vasmatzis

Co-Director - Biomarker Discovery Program

Mayo Clinic

Heinrich Roder

Chief Technology Officer

Biodesix

Jadwiga Bienkowska

Senior Director & Head of Computational Biology & Oncology Research

Pfizer

JD Schonhoft

Senior Principal Scientist - Translational Medicine

Repare Therapeutics

Jean-Francois Martini

Senior Director - Translational Oncology Lead Global Product Development Translational Oncology

Pfizer

Jennifer Skenfield

Director - Clinical Operations, Oncology & Early Development

Gilead

Jess Lambe

Director, CDx Partnering

Illumina

Jim Godsey

Vice President – Advanced Diagnostics

Quest Diagnostics

Johan Skog

Chief Scientific Officer & Vice President, ExosomeDx

a Bio-Techne Brand

Julien Senac

Global Director, IVD Focus Team & Strategic Account Manager

TÜV SÜD

June Lu

Sr. Director

BeyondSpring Pharmaceuticals Inc.

Kara Bortone

Senior Director

Janssen

Kate Kalashnikova

Associate Director - Translational Medicine

Natera

Kevin Keegan

General Manager of Oncology

Illumina

Kirk Tanner

CSO and SVP Brain Tumor Investment Fund

National Brain Tumor Society

Lauren Leiman

Executive Director

BloodPAC

Lucas Dennis

Vice President - Franchise Development in R&D

Foundation Medicine

Marielena Mata

Free Agent, Formerly at Pfizer

Pfizer

Mark Gardner

Senior Vice President - Genomic Medicine and Oncology

Quest Diagnostics

Mark Stewart

Vice President, Science Policy

Friends of Cancer Research

Matthew Pink

Senior Director - Business Development

Biodesix

Mike Damore

Director - Translational Oncology Lead

Pfizer

Nicholas Gallerani

Scientific Affairs

NuProbe

Nike Beaubier

Senior Vice President

Tempus Labs

Nikki Martin

Senior Director, Precision Medicine Initiatives

LUNGevity

Olivier Harismendy

Director, Head of Computational Biology

Zentalis Pharmaceuticals

Pashtoon Kasi

Assistant Professor of Medicine

Weill Cornell Medical College

Phillipe Mourere

President & Chief Executive Officer

Stilla Technologies

Qu Zhang

Director - Clinical Biomarkers & Immuno-Oncology

GSK

Ranjan J. Perera

Director RNA Centre, Associate Professor

Johns Hopkins School of Medicine

Raphael Clynes

Vice President - Translational Biology

Xencor

Robert McCormack

Principal

Independent Consultant

Sam Hong

Director - Global Health Economics & Outcomes Research

Agilent Technologies

Sarah Paul Shagan

Senior Scientific Manager - Biomarker Lead

Genenetch

Scott Shell

Medical Science Liaison, Medical Affairs

Guardant Health

Sean Boyle

Executive Director, Bioinformatics Science

Personalis

Shile Zhang

Associate Director - Bioinformatics

Guardant Health

Shrividya Iyer

Executive Director - Oncology Global Real World Evidence, Health Economics & Outcomes Research

Eisai

Stacey Adam

Associate Vice President - Research Partnerships

Foundation for the National Institutes of Health

Sunanatha Setharuman

Principal Scientist - Clinical Bioinformatics

Repare Therapeutics

Taylor Jensen

Vice President, Head of Oncology Science

LabCorp

Trevor Page

Senior Vice President & General Manager

Grail

Vamsi Parimi

Medical Director, Molecular Pathology

Seagen

Yu Liang

Director - Clinical Biomarker

Compugen

Zhenhao Qi

Director, Global Companion Diagnostics Lead Global Companion Diagnostics Global Oncology R&D

Daiichi Sankyo